Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

André Do

Biographic Data

ID7591599
NAMEAndré Do
GIVEN NAMESAndré
FAMILY NAMEDo
SIGNATUREDO A
AFFILIATIONSUniversité de Montréal
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2024
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Probable Serotonin Syndrome Precipitated by the Addition of Trazodone to Lurasidone and Valproic Acid

    Open Access•André Do, Raffi Kachichian et al.•ARTICLE•Santé mentale au Québec•2026

    Serotonin syndrome (SS) is a serious medical condition characterized by altered mental status, autonomic instability and neuromuscular abnormalities. It is caused by the use of one or multiple serotoninergic medication(s), which results in excessive activation of serotoninergic receptors. Here, we present a case of probable SS following the addition of trazodone to treat insomnia. Besides trazodone, the patient was prescribed valproic acid, luras…

  • Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy

    Open Access•André Do, Vanessa Michaud et al.•ARTICLE•Frontiers in Psychiatry•2024

    Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case of an adult patient with DTD who received psilocybin-…

No prominent works on this page.

  • Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy

    Open Access•André Do, Vanessa Michaud et al.•ARTICLE•Frontiers in Psychiatry•2024

    Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case of an adult patient with DTD who received psilocybin-…

  • Probable Serotonin Syndrome Precipitated by the Addition of Trazodone to Lurasidone and Valproic Acid

    Open Access•André Do, Raffi Kachichian et al.•ARTICLE•Santé mentale au Québec•2026

    Serotonin syndrome (SS) is a serious medical condition characterized by altered mental status, autonomic instability and neuromuscular abnormalities. It is caused by the use of one or multiple serotoninergic medication(s), which results in excessive activation of serotoninergic receptors. Here, we present a case of probable SS following the addition of trazodone to treat insomnia. Besides trazodone, the patient was prescribed valproic acid, luras…

Serotonergic (2 works) · Serotonin (2 works) · Adverse effect (1 work) · Alternative medicine (1 work) · Antidepressant (1 work) · Antipsychotic (1 work) · Anxiety (1 work) · Chemical synthesis and alkaloids (1 work) · Discontinuation (1 work) · Duloxetine (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae